Newsletter sign-up

American Diabetes Association Meeting, Orlando
Friday, 22 June 2018

We look forward to attending this conference, where the results of the large scale Randomised Controlled trial with our technology will be presented in public for the first time by the Principle Investigators in the study.

< Back to overview

Dr. Magnus Löndahl presented Clinical experiences with LeucoPatch and the status of the large RCT at the Innovations in Wound Healing meeting.

by Rasmus Lundquist

MD, PhD Magnus Löndahl one of 4 principal investigators of the large randomized controlled trial of LeucoPatch/3C Patch on diabetic foot ulcers presented “Clinical experiences with LeucoPatch and status of the large RCT: Leucopatch™ System in the Management of Hard-To-Heal Diabetic Foot Ulcers” at the 4th annual Innovations in Wound Healing meeting December 9th 2017 in Bimini, Bahamas. In addition, PostDoc Jonas Schmidt was selected to present data supporting the proposed mode of action. Interest among the mainly US clinicians was high and they were pleased to hear that all patients have been finalized and the database closed for analysis. Just like the Reapplix team, they too are eagerly awaiting publication of the results in 2018.

Top